KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Taxes: 2013-2014

Historic Current Taxes for Teva Pharmaceutical Industries (TEVA) over the last 2 years, with Dec 2014 value amounting to $16.6 million.

  • Teva Pharmaceutical Industries' Current Taxes was N/A to $38.7 million in Q3 2015 from the same period last year, while for Sep 2015 it was $38.7 million, marking a year-over-year change of. This contributed to the annual value of $16.6 million for FY2014, which is 22.96% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Current Taxes of $16.6 million as of FY2014, which was up 22.96% from $13.5 million recorded in FY2013.
  • In the past 5 years, Teva Pharmaceutical Industries' Current Taxes ranged from a high of $16.6 million in FY2014 and a low of $13.5 million during FY2013.
  • Over the past 2 years, Teva Pharmaceutical Industries' median Current Taxes value was $15.1 million (recorded in 2013), while the average stood at $15.1 million.
  • Data for Teva Pharmaceutical Industries' Current Taxes shows a peak YoY climbed of 22.96% (in 2014) over the last 5 years.
  • Over the past 2 years, Teva Pharmaceutical Industries' Current Taxes (Yearly) stood at $13.5 million in 2013, then rose by 22.96% to $16.6 million in 2014.